Shares of TG Therapeutics, Inc. TGTX have rallied 29.5% in the past three months against the industry’s decline of 11.2%. The company’s sole marketed drug Briumvi (ublituximab-xiiy) was approved by ...
The biotech wins approval for a multiple sclerosis drug. It plans to launch the treatment commercially in the first quarter of 2023. On Wednesday, TG Therapeutics divulged the happy news that it ...
2d
"tg-bie"
The Telangana Intermediate Public Examinations (IPE) 2026 will commence from February 25. Over nine lakh students are expected to appear. TG BIE will issue a detailed timetable, and exam fees have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback